QR Code

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME

Aim. To estimate the levels of of plasminogen (Pg) and inhibitor of plasminogen activators of type 1 (IPA-1) in patients with antiphospholipid syndrome (APS) and to reveal correlations between their content and clinical-laboratory characteristics of APS. Material and methods. A Pg level was measured...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: E V Ostryakova, T M Reshetnyak, R B Aisina, L I Mukhametova, D A Gulin, E N Alexandrova, N V Seredavkina, S D Varfolomeev, A V Chernyakov, Yu V Nikiforov, E L Nasonov
Hōputu: Artigo
Reo:Russo
I whakaputaina: "Consilium Medicum" Publishing house 2012-05-01
Rangatū:Терапевтический архив
Ngā marau:
antiphospholipid syndrome
antiphospholipid antibodies
plasminogen
inhibitor of plasminogen activators of type 1
systemic lupus erythematosus
idiopathic thrombosis
thrombosis
antibodies to cardiolipin
antibodies to beta2-glycoprotein of type 1
Urunga tuihono:https://ter-arkhiv.ru/0040-3660/article/view/31046
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite